Calcium Phosphate Scaffold with Polyphenol Sustained Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current osteoporosis treatments, such as bisphosphonate-based drugs and growth factors, have limitations including side effects, high costs, and difficulties in achieving sustained release and bioactivity, particularly in ceramic scaffolds used for bone regeneration, which are not suitable for osteoporosis patients due to differences in bone regeneration rates and mechanical properties.
Innovation Solution
A scaffold for hard tissue regeneration is developed using a polyphenol-based natural substance like Quercetein or Genistein, which is evenly introduced into a calcium phosphate ceramic scaffold, allowing for room temperature processing and sustained release, promoting osteoblast activity while inhibiting osteoclast activity, thereby enhancing bone regeneration without the drawbacks of conventional treatments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If high temperature sintering is used to prepare ceramic scaffold, then mechanical properties and bioactivity are improved, but thermal-sensitive drugs and growth factors are degraded
Solution Approach 1:
The preparation process is divided into two separate stages: first, the ceramic scaffold is prepared through high-temperature sintering to achieve desired mechanical properties; second, the thermal-sensitive drugs or growth factors are introduced into the pre-formed scaffold pores through adsorption or infiltration. This segmentation allows each component to be optimized independently without mutual interference.
Solution Approach 2:
The ceramic scaffold structure is prepared in advance through high-temperature sintering before introducing the thermal-sensitive active ingredients. By performing the high-temperature processing first and then adding the drugs/growth factors to the cooled scaffold, the beneficial mechanical properties are achieved while protecting the thermal-sensitive components from degradation.
2Ease of manufacture
If drug is adsorbed on scaffold surface after sintering, then drug incorporation is simple, but drug release is quick and sustained-release is difficult
Solution Approach 1:
The ceramic scaffold utilizes its inherent porous structure created during sintering as the drug delivery vehicle. The pores provide internal volume for drug incorporation through infiltration or adsorption, enabling the drug to be distributed throughout the scaffold matrix rather than just on the surface. This porous architecture naturally facilitates sustained release by controlling diffusion pathways and surface area exposure.
3Device complexity
If osteoporosis patients receive general porous scaffold, then scaffold structure is simple, but bone regeneration is hindered due to physical property differences
Solution Approach 1:
The scaffold is designed as a composite material system combining ceramic base material with osteoporosis-specific active ingredients (such as bone morphogenic proteins, osteoblast-stimulating factors, or osteoclast-inhibiting agents). This composite approach allows the scaffold to address both the structural support needs and the specific pathophysiological conditions of osteoporosis, enhancing bone regeneration despite the relatively simple overall scaffold architecture.
4Ease of operation
If bone graft material is transplanted to osteoporosis patients, then transplantation is straightforward, but secondary bone damage occurs due to physical property differences
Solution Approach 1:
The scaffold parameters (such as porosity, pore size distribution, surface area, and mechanical strength) are specifically adjusted and optimized to match the altered bone properties of osteoporosis patients. By changing these physical parameters to accommodate the weaker, more porous bone structure characteristic of osteoporosis, the scaffold provides appropriate mechanical support without causing stress concentration or secondary damage during transplantation and integration.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The scaffold effectively improves osteoblast activity and suppresses osteoclast activity, leading to enhanced bone regeneration with reduced side effects and costs, and achieves long-term sustained release of the active ingredient, making it suitable for osteoporosis treatment.
Implementation Method 1
a scaffold for hard tissue regeneration comprising an active ingredient for treating osteoporosis and calcium phosphate ceramic
Implementation Method 2
promoting osteoblast activity while inhibiting osteoclast activity, thereby enhancing bone regeneration
Data Source
AI summary
A scaffold for hard tissue regeneration comprising an active ingredient for treating osteoporosis and a preparation method thereof. The scaffold for hard tissue regeneration is prepared by the steps of mixing a polyphenol-based natural substance containing Quercetein or Genistein involved in the activation of osteoblasts and osteoclasts and the biofunctional analog thereof with a ceramic scaffold material and molding the mixture at room temperature into a three-dimensional scaffold. The biofunctional material included in the scaffold above may be sustain-released slowly over the long period of time so that the osteoblast activity is directly improved and at the same time the osteoclast activity is suppressed in the course of bone regeneration, to have the effect of improving bone regeneration.